COVID: mRNA vaccine anaphylaxis -- ?overblown
Anaphylaxis is a rare event after the mRNA vaccines, apparently more common with the Pfizer one (see covid mRNA vaccine anaphylaxis jama2021 in dropbox, or doi:10.1016/j.vaccine.2015.07.035) Details: -- this is an updated report of anaphylaxis from both the Pfizer and Moderna vaccines, after the initial reports finding the Pfizer vaccine had 11.1 cases per million doses and the Moderna vaccine 2.5 per million doses. -- the current report is based on the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis at levels 1, 2, or 3, after 9,943,247 doses of the Pfizer vaccine and 7,581,429 doses of Moderna were administered -- Brighton Collaboration anaphylaxis level: level 1 occurred in 50%, level 2 in 45% and level 3 in 5% (level 1 is the worst) --for the Brighton Collaboration anaphylaxis criteria, see https://www.spsu.ch/en/docs/media/273d46e0-5363-49c4-aec8-a2d190b75acf/4692a94e...